Request for advisory committee nominations: patient organizations and individuals

Request for advisory committee nominations: patient organizations and individuals  At FDA, we rely on our many advisory committees to help us make sound decisions based on the best science available. Advisory committee meetings can include a broad scientific discussion about important topics, such as the development of vaccines for COVID-19. They can also be more focused on a specific product under FDA review.    FDA is requesting nominations for voting and/or nonvoting patient representatives to serve on advisory committees and/or panels for which vacancies currently exist or are expected to occur in the near future. For advisory committee vacancies listed in this notice, and those that may occur through December 31, 2023:  Patient organizations:  Patient organizations interested in participating in the selection of an appropriate voting or nonvoting member to represent patient interests on an FDA advisory committee or panel may send a letter or email (to ACOMSSubmissions@fda.hhs.gov) stating that interest to FDA by August 15, 2022.  Patient representatives:   Nominees recommended to serve as a voting or nonvoting patient representative may be self-nominated or may be nominated by a patient organization. FDA seeks to include the views of individuals on its advisory committee regardless of their gender identification, religious affiliation, racial and ethnic identification, or disability status and, therefore, encourages nominations of appropriately qualified candidates from all groups. Patient representative nominations should be submitted electronically through the FDA Advisory Committee Membership Nomination Portal, by August 15, 2022. Alternatively, materials may be submitted by mail at the addresses noted in the Federal Register notice.  Learn more Federal Register notice: Requests for Nominations: Individuals and Consumer Organizations for Advisory Committees (July 1, 2022) Consumer Update: Advisory Committees Give FDA Critical Advice and the Public a Voice Applying for Membership on FDA Advisory Committees Consumer Representatives on FDA Advisory Committees   Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA